Indefinite Delivery Contract 36E79721D0022

Award Date 5/16/21
Last Date to Order 5/15/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
The federal contract IDV award SPE2D223D0002 is a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the manufacture and distribution of branded and generic pharmaceutical products. The $23.3 million IDC was awarded on October 6, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 5, 2027. The IDC utilizes firm-fixed pricing and provides an uninterrupted supply...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the supply of Clopidogrel Bisulfate tablets. The $15,979,579.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of April 14, 2026. The contract aims to provide an uninterrupted supply of Clopidogrel Bisulfate tablets in various bottle...
The federal contract IDV SPE2D221D0130 is a single-award indefinite delivery contract awarded to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The $15.9 million contract has a period of performance through June 20, 2026 and was issued by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The contract aims to establish a national supply source for several high-volume pharmaceutical products including gabapentin,...
The Department of Veterans Affairs National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc. for the supply of atorvastatin calcium tablets over a base year and four one-year option periods. The $72.3M contract provides an uninterrupted source of these pharmaceuticals to support the medication requirements of the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The pre-solicitation notice indicates the agency will issue a full...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the provision of gabapentin tablets. The $23.5 million IDC has a base year and four one-year option periods, with an ultimate completion date of December 31, 2025. The contract aims to establish a reliable source of supply for high-volume gabapentin tablets in various strengths and...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer. The contract has a base year from November 26, 2022 to November 25, 2023, with four one-year option periods, for a total ceiling value of $7,616,074.14. The contract is for the supply of four line items of chlorthalidone tablets in 25mg and 50mg sizes, to be distributed through the VA and...
The National Acquisition Center, a civilian agency within the Department of Veterans Affairs, awarded a single-award indefinite delivery contract to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business manufacturer, to provide 6 line items of fluoxetine HCL capsules in various strengths and bottle configurations. The $10,673,128.95 contract has a base year from December 10, 2022 to December 9, 2023, plus four one-year option periods, for an estimated annual requirement of...

This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021 to May 15, 2022, with four one-year option periods.

The contract aims to establish a reliable source of supply for these high-volume pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor programs, allowing the government to obtain discounted pricing. Radha Pharmaceuticals is an experienced manufacturer and distributor of generic drugs, holding multiple IDCs with the VA and DLA to provide a range of tablets and capsules. This IDC was awarded under full and open competition with no set-asides applied, streamlining the procurement of these essential medications for beneficiary care at government medical facilities.

Generated 4/25/25, 10:36 AM